Abbott India EV/EBIT
Was ist das EV/EBIT von Abbott India?
EV/EBIT von Abbott India Limited ist 39.90
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Abbott India
Was macht Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
Unternehmen mit ev/ebit ähnlich Abbott India
- CAST SA hat EV/EBIT von 39.82
- Lonza AG hat EV/EBIT von 39.83
- Zenith Healthcare hat EV/EBIT von 39.87
- CR Constr Grp Hldg Ltd hat EV/EBIT von 39.88
- Terreno Realty Corp hat EV/EBIT von 39.89
- Tiffany & Co hat EV/EBIT von 39.90
- Abbott India hat EV/EBIT von 39.90
- Neogen Chemicals hat EV/EBIT von 39.92
- The Bombay Dyeing and Manufacturing hat EV/EBIT von 39.94
- GHP Noetic Science-Psychedelic Pharma hat EV/EBIT von 39.95
- N.B.I. Industrial Finance hat EV/EBIT von 39.95
- Texmaco Rail & Engineering hat EV/EBIT von 39.96
- Shift4 Payments hat EV/EBIT von 39.97